- USask VIDO-InterVac and International Vaccine Institute collaborate on COVID-19 work
IVI of South Korea, a world-renowned international organization founded by the United Nations Development Programme, is collaborating with VIDO-InterVac to better understand the virus causing COVID-19 and to develop vaccines and potential treatments.
- Saskatchewan government invests $3.6M in USask COVID-19 vaccine research
The Government of Saskatchewan has announced $3.6 million in new funding for VIDO-InterVac one of the world’s most advanced infectious disease labs and a leader in global efforts to find a COVID-19 vaccine.
- New Money Aids Saskatchewan’s Search For Covid-19 Vaccine
The Government of Saskatchewan and the Federal Government are committing $28 million to VIDO-InterVac to develop a vaccine for COVID-19.
- PM announces $12M for new vaccine manufacturing at USask’s VIDO-InterVac, part of $23.3M for the lab to fight COVID-19 and other infectious disease threats
As the COVID-19 outbreak continues to rapidly evolve, the federal government announced $23.3 million to support VIDO-InterVac, one of the largest and most advanced infectious disease research facilities in the world.
- Canada’s plan to mobilize science to fight COVID-19
Funding to strengthen COVID-19 vaccine development and expand bio-manufacturing capacity to support clinical trials
- VIDO-InterVac team tackles coronavirus: Researchers developing prototype vaccines at USask
VIDO-InterVac researchers have successfully grown the virus in a cell culture and are now testing a new vaccine in animals as part of the global effort to combat the coronavirus threat.
- Saskatchewan Funds Coronavirus Vaccine Research
Innovation Saskatchewan is providing researchers at the VIDO-InterVac with $200,000 to help find a vaccine for COVID-19.
- VIDO-InterVac-led research team at USask awarded almost $1M to fight new coronavirus
Researchers and collaborating scientists from across the country have been awarded almost $1 million over two years to develop animal models and test vaccine candidates for effectiveness and safety against the new coronavirus.
- Canadian scientists first to test novel diagnostic tool for TB in bison
To help protect Canada’s cattle and bison and maintain the country’s bovine tuberculosis-free status, scientists are conducting trials in bison of several diagnostic tools, including the Actiphage® blood test developed by PBD Biotech.
- VIDO-InterVac approved to work on SARS-CoV-2
Researchers have received permission from the Public Health Agency of Canada to start working on a vaccine for the coronavirus recently discovered in China, and they hope to have first candidates for testing in an animal model in six to eight weeks.